What is the usage and recommendation for Zoely (estradiol and nomegestrol acetate) tablets as a contraceptive method?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Zoely (Nomegestrol Acetate/Estradiol) Contraceptive Tablets

Zoely is a highly effective monophasic combined oral contraceptive containing nomegestrol acetate (NOMAC) 2.5mg and 17β-estradiol (E2) 1.5mg that should be taken in a 24/4-day regimen (24 active pills followed by 4 placebo pills) with excellent contraceptive efficacy and favorable safety profile. 1, 2, 3

Composition and Unique Features

  • First monophasic combined oral contraceptive containing natural 17β-estradiol instead of ethinyl estradiol 4
  • Contains nomegestrol acetate (NOMAC), a highly selective progestogen derived from 19-norprogesterone 5
  • Administered in a 24/4 regimen (24 active tablets followed by 4 placebo tablets) 2

Efficacy

  • Pearl Index of 0.38 in European studies and 1.13 in US studies, indicating high contraceptive reliability 4
  • Particularly effective in overweight and obese patients 1
  • High antigonadotropic activity and long elimination half-life (approximately 50 hours) help maintain contraceptive efficacy even when doses are missed 5

Safety Profile and Metabolic Effects

  • Minimal impact on:

    • Hemostasis and blood clotting factors
    • Lipid profile
    • Carbohydrate metabolism
    • Blood pressure
    • Bone mineral density 1, 4
  • Contains natural estradiol rather than ethinyl estradiol, which may potentially reduce thrombotic side effects typically associated with combined oral contraceptives 3

Cycle Control and Bleeding Pattern

  • Provides good cycle control comparable to pills containing ethinyl estradiol 5
  • Withdrawal bleedings are typically shorter and lighter compared to other combined hormonal contraceptives 2
  • Approximately 30% of women experience absence of withdrawal bleeding after 12 months of use 4

Side Effects and Tolerability

  • Generally well tolerated with an acceptable safety profile 2
  • Most common adverse events include:
    • Acne (may be less favorable compared to some other combined pills)
    • Abnormal withdrawal bleeding (shorter, lighter, or absent periods) 2
  • Minimal weight gain reported 1

Usage Instructions

  • If starting Zoely or switching from another hormonal contraceptive, follow the standard recommendations for combined oral contraceptives 6

  • If one pill is late (less than 24 hours since it should have been taken):

    • Take the missed pill as soon as possible
    • Continue taking remaining pills at the usual time
    • No additional contraceptive protection needed 6
  • If one pill is missed (24 to <48 hours since it should have been taken):

    • Take the most recent missed pill as soon as possible
    • Continue taking remaining pills at the usual time
    • Use backup contraception for 7 consecutive days 6
  • If two or more consecutive pills are missed (≥48 hours):

    • Take the most recent missed pill immediately
    • Use backup contraception until pills have been taken for 7 consecutive days
    • Consider emergency contraception if pills were missed during the first week and unprotected intercourse occurred 6

Special Considerations

  • Fast recovery of ovarian activity after discontinuation makes it suitable for women planning future pregnancies 1
  • In case of vomiting or severe diarrhea within 24 hours of taking a pill, follow the missed pill guidelines 6
  • Like all combined hormonal contraceptives, Zoely does not protect against sexually transmitted infections 6

Caution

While Zoely has a favorable metabolic profile, it shares the same contraindications as other combined hormonal contraceptives, including history of venous thromboembolism, migraine with aura, and certain cardiovascular risk factors 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.